PLASOMA Efficacy & Technology Health (PETH) Study
PLASOMA Efficacy & Technology Health (PETH) Study: A Post-market Randomised Controlled Efficacy Study of PLASOMA on Wound Healing in Chronic Venous Leg Ulcers
Sponsor: European Commission
Terminated
The continuation of the study was rendered unreasonable due to the slow inclusion rate
Other terminated trials from European Commission
Other Venous Leg Ulcer trials with similar outcome
This NA trial investigates Venous Leg Ulcer and is currently terminated or withdrawn. European Commission leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2024 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2022 — Jan 2024 [monthly]
Recruiting NA
-
Dec 2021 — Sep 2022 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Oct 2021 — Dec 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
First recorded
Jun 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- European Commission
- Plasmacure
For direct contact, visit the study record on ClinicalTrials.gov .